Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: diabetes


Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier


One blood test to diagnose diabetes? HealthDay doesn’t address harms of overdiagnosis and overtreatment


LA Times provides careful take on early brain/diabetes research–except for the headline


NPR story about online weight loss program left out a key detail: How much does it cost?


When weight loss is the intervention, it’s still important to talk about costs and harms


AP’s write-up on a new continuous blood sugar monitor–where’s the proof that it works?


Can these 10 foods really ‘cut risk of early death’? NPR overstates the evidence


Independent source and costs: All that’s missing from otherwise solid Reuters story on Victoza


Guardian predicts end to insulin shots based on rehashed news release, mouse research


Reuters story on oral insulin trial needed sources beyond drug company CEO